Giant Biogene Holding Co. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Chicmax Cosmetics Co., Ltd.

Hengan International Group Co., Ltd.

L'Occitane International SA

Giant Biogene Holding Co. Ltd.

Vinda International Holdings Ltd.

Blue Moon Group Holdings Ltd.

Natural Beauty Bio-Technology Ltd.

China Ludao Technology Co. Ltd.

Evergreen Products Group Ltd.

Precious Dragon Technology Holdings Ltd.

China Golden Classic Group Ltd.

Why is Giant Biogene Holding Co. Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

The company is Net-Debt Free

The company has declared negative results in Dec'2025 after 3 consecutive positive quarters

ROCE(HY) Lowest at 22.27%
INTEREST COVERAGE RATIO(Q) Lowest at 452,292.13
RAW MATERIAL COST(Y) Grown by 5.6% (YoY)

With ROE of 0.02%, it has a Very Expensive valuation with a 3.26 Price to Book Value

Over the past year, while the stock has generated a return of -66.27%, its profits have risen by 23.8%

Below par performance in long term as well as near term

Along with generating -66.27% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Giant Biogene Holding Co. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Giant Biogene Holding Co. Ltd.

-66.27%

-0.97

47.64%

Hang Seng Hong Kong

8.76%

0.45

19.63%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

22.36%

EBIT Growth (5y)

33.69%

EBIT to Interest (avg)

2.64

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.82

Sales to Capital Employed (avg)

11.53

Tax Ratio

37.90%

Dividend Payout Ratio

31.32%

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

14330

Industry P/E

Price to Book Value

3.26

EV to EBIT

6684.80

EV to EBITDA

6265.73

EV to Capital Employed

65.70

EV to Sales

250.69

PEG Ratio

Dividend Yield

ROCE (Latest)

0.98%

ROE (Latest)

0.02%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

NO KEY POSITIVE TRIGGERS

-11What is not working for the Company

ROCE(HY)

Lowest at 22.27%

INTEREST COVERAGE RATIO(Q)

Lowest at 452,292.13

RAW MATERIAL COST(Y)

Grown by 5.6% (YoY

OPERATING PROFIT(Q)

Lowest at HKD 881.37 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 33.46 %

PRE-TAX PROFIT(Q)

Lowest at HKD 926.97 MM

NET PROFIT(Q)

Lowest at HKD 758.13 MM

EPS(Q)

Lowest at HKD 0.75

Here's what is working for Giant Biogene Holding Co. Ltd.

Depreciation

Highest at HKD 48.58 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 48.58 MM has Grown at 19.42%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Giant Biogene Holding Co. Ltd.

Interest Coverage Ratio

Lowest at 452,292.13

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at HKD 881.37 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin

Lowest at 33.46 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at HKD 926.97 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit

Lowest at HKD 758.13 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (HKD MM)

EPS

Lowest at HKD 0.75

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Raw Material Cost

Grown by 5.6% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income

Highest at HKD 0.1 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income